Pre-Conference Training Session June 15-17
(at WADOH):

This class is now closed! No longer taking registrations!

Workshop on Rapid Test Kits for Natural Toxins, Veterinary Residues and Allergens. Hosted by Jim Hungerford.

Please click here for a PDF flyer with details and description.

Please click here for the additional Registration Form for this training.

Thursday Morning Training Sessions
(at UPS conference site):


MICROBIOLOGICAL TRAINING -- Single Laboratory Validation of Microbiological Methods. Given by Sharon Brunelle.

This training session is designed to give attendees an understanding of the Research Institute’s Performance Tested MethodsSM (RI PTM) Program for validating proprietary rapid microbiology methods. There will be specific information given for developers, independent laboratories and end users of rapid methods. The presentations will include an overview of the RI PTM program, detailed information and suggestions on performing the laboratory work necessary for a validation study along with specifics and examples of the current recommended statistical analyses for microbiological method validation.

Evolution of the AOAC Validation Process

Given by Mark C. Roman, President, Tampa Bay Analytical Research, Inc., Largo, FL 33777

In 2001, the National Institutes of Health Office of Dietary Supplements (NIH-ODS) entered into an inter-agency agreement with FDA to fund a contract with AOAC to validate methods for the determination of ephedrine alkaloids in ephedra botanical products and dietary supplements. This contract was expanded in 2003/2004, and reached its completion this past March. As a result of this contract, AOAC implemented many changes in its validation process which has affected all areas and communities within AOAC. These changes include placing a greater emphasis on single laboratory validations, establishment of single laboratory validation guidelines, the use of expert review panels to recommend methods and materials for study, the development of training courses, and many others. This educational session will provide a brief overview of the AOAC validation process prior to 2001, the changes and programs implemented since then, lessons learned from the NIH/FDA contract, and suggestions for future improvements to the program.